Skip to main content
Premium Trial:

Request an Annual Quote

Horizon Secures Distribution Rights to New X-Man Cell Lines from Japanese University

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – UK firm Horizon Discovery today announced it has been granted an exclusive worldwide license by Public University Corporation Yokohama City University (YCU) for 50 new X-Man cell lines.

The cell lines are focused on DNA repair and include important double knockout cell lines, Horizon said, noting that they complement the UK firm's existing X-Man DNA repair panel in the HCT-116 colon cell line.

The new lines are in the NALM-6 cell line, a B-cell derived line. As a result of the deal, Horizon's panel of X-Man cell lines now includes B-cells.

Horizon will pay YCU upfront and ongoing royalty payments as part of the deal. In exchange, it receives the exclusive, worldwide rights to distribute the cell lines. The agreement supports Horizon's strategy to generate at least 2,500 new X-man models of cancer, neurodegenerative, and cardiovascular disease, it said.

The new cell lines will enable researchers to learn more about the role of DNA repair in leukemia, while providing a new model for other diseases. Horizon added that they will provide insight into how genetic diseases manifest themselves in patients and help rationalize many aspects of new-drug development.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.